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Spontaneous calcium oscillationSpontaneous Ca2+ events have been observed in diverse stem cell lines, including carcinoma and
mesenchymal stem cells. Interestingly, during cell cycle progression, cells exhibit Ca2+ transients during the
G1 to S transition, suggesting that these oscillations may play a role in cell cycle progression. We aimed to
study the inﬂuence of promoting and blocking calcium oscillations in cell proliferation and cell cycle
progression, both in neural progenitor and undifferentiated cells. We also identiﬁed which calcium stores are
required for maintaining these oscillations. Both in neural progenitor and undifferentiated cells calcium
oscillations were restricted to the G1/S transition, suggesting a role for these events in progression of the cell
cycle. Maintenance of the oscillations required calcium inﬂux only through inositol 1,4,5-triphosphate
receptors (IP3Rs) and L-type channels in undifferentiated cells, while neural progenitor cells also utilized
ryanodine-sensitive stores. Interestingly, promoting calcium oscillations through IP3R agonists increased
both proliferation and levels of cell cycle regulators such as cyclins A and E. Conversely, blocking calcium
events with IP3R antagonists had the opposite effect in both undifferentiated and neural progenitor cells. This
suggests that calcium events created by IP3Rs may be involved in cell cycle progression and proliferation,
possibly due to regulation of cyclin levels, both in undifferentiated cells and in neural progenitor cells.
Published by Elsevier B.V.1. Introduction
Cell cycle progression in mammalian somatic cells is known to be
dependent on intracellular Ca2+ signaling [1,2]. Accordingly, previous
reports showed that spontaneous Ca2+ events were observed in the
G0/G1 phases of the cell cycle, suggesting a possible role for these
events in reentry into the cell cycle [3]. Furthermore, G1/S and G2/M
transitions are also coupled to increases in spontaneous Ca2+
oscillations, which were demonstrated to be dependent on inositol
1,4,5-triphosphate receptors, (IP3Rs) [2,4].
Cell cycle progression is known to require Ca2+ inﬂux from both
extra- and intracellular sources. Accordingly, calcium removal from
the extracellular solution and inhibition of replenishment of endo-
plasmic reticulum (ER) calcium stores result in arrest of the cell cycleute of Exacts Sciences, Federal
270-901, Belo Horizonte, MG,
.
santacasabh.org.br
B.V.in the G1/S transition [5,6]. Calcium inﬂux from internal (through
ryanodine receptors and IP3Rs) and external stores (via store-
operated Ca2+ channels and voltage gated calcium channels) are
involved in cell proliferation [5,7–12].
Calcium wave-signaling is widespread, as it has been observed in
cortical radial glia, in the ventricular zone [7,8], neurospheres [9],
mesenchymal stem cells [10,13], mouse embryonic stem cells [11],
mouse carcinoma stem cells [13] and cells in developing tissue
[12,14–16]. Although calcium oscillations have been observed in
numerous model systems, many questions about the role of these
Ca2+ events in cell cycle progression and cellular proliferation remain
unanswered. For instance, it is not known if the calcium stores
necessary tomaintain these calcium events are the same in embryonic
and adult stem cells, or if they are conserved across neuronal
differentiation. The mechanisms through which calcium events
regulate cellular proliferation and progression of the cell cycle are
also unknown. In the present work, to investigate these issues, we
studied calcium oscillations throughout the cell cycle in undifferen-
tiated and neural progenitor cells (NPCs), and identiﬁed which
calcium stores are necessary for the occurrence of these oscillations.
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proliferation and progression of the cell cycle. To this end we used
stem cells derived from embryonic (P19 embryonic carcinoma stem
cells, or CSCs) and adult tissue (murine bone-marrow derived
mesenchymal stem cells, or MSCs). We show that calcium events are
regulated by IP3Rs in undifferentiated stem cells and by IP3Rs and
ryanodine receptors (RyRs) in neural progenitor cells. Interestingly,
spontaneous Ca2+ oscillations were restricted to the G1/S phase
transition of the cell cycle, suggestive of a role for these oscillations in
cell cycle progression. Lastly, blocking calcium oscillations with IP3R
antagonists decreased proliferation and blocked progression of the cell
cycle,while promoting calciumoscillationswith IP3Rs agonists had the
opposite effect, both in CSCs and MSCs. Importantly, we demonstrate
that IP3R-mediated pathways modulate proliferation and progression
of the cell cycle in a similar fashion in both undifferentiated cells and
neural progenitor cells. We also show that the previously reported
association between IP3Rs and proliferation [17] may be due to an
IP3R-mediated increase in the expression levels of cyclins A and E.
Thus, our data show that IP3Rs regulate both the cell cycle and calcium
oscillations. These ﬁndings support a possible role for calcium
oscillations in progression of the cell cycle. These effects were
observed in both stem cells and neural progenitor cells derived from
embryonic carcinoma and adult stem cells, suggesting it may be a
conserved mechanism for stem cells from different origins.
2. Materials and methods
2.1. Reagents
Unless indicated otherwise, all reagents were purchased from
Sigma (St. Louis, MO). Primers for Real Time PCR reactions were
synthesized by Integrated DNA Technologies (Coralville, IA). The
following antibodies were used for immunoprecipitation andWestern
blots: sc-601-G against CDK4, sc-163-G against CDK2, sc-177 against
CDK6, sc-751 against cyclin A, sc-481 against cyclin E (all purchased
from Santa Cruz Biotechnology); mouse monoclonal antibody to
mouse p27 (K25020) (Transduction Laboratories, Lexington, KY);
mouse monoclonal antibodies against cyclin A (Ab-1, E23) and cyclin
D2 (Ab-4, DCS-3.1 + DCS-5.2) [18] (Abcam, Cambridge, UK); mouse
monoclonal antibody against the C-terminal of human cyclin D3,
which cross-reacts with the mouse homologue (DCS-22) [19]. Anti-
nestin (Chemicon International Inc., Temecula, CA), anti-NEL (Santa
Cruz Biotechnology, Delaware, CA) and secondary antibodies coupled
with cytochrome 3 (Cy3, 1:200, Jackson Immunoresearch, West
Grove, PA). The following polyclonal rabbit antisera were used: anti-
nestin, anti-neuronal enolase (NEL), anti-SSEA-1 (Santa Cruz Bio-
technology, Heidelberg, Germany) and anti-β-actin.
2.2. Culture and neuronal differentiation of CSC cells
P19 embryonic carcinoma cells (CSCs) cells (kindly provided by
Prof. Dr. José Garcia Ribeiro Abreu Jr., ICB, UFRJ) were maintained in
Dulbecco's modiﬁed Eagle's medium (DMEM, Invitrogen, Carlsbad,
CA) supplemented with 10% fetal bovine serum (FBS, Cultilab,
Campinas, Brazil), 100 units/ml penicillin, 100 μg/ml streptomycin,
2 mM L-glutamine, and 2 mM sodium pyruvate and in a humidiﬁed
incubator at 5% CO2 and 37 °C. For neuronal differentiation induction
experiments, cells were exposed to 1 mM of all trans-retinoic acid
(RA). Formation of embryonic bodies (EBs) was induced by culturing
P19 cells in suspension in bacterial culture dishes coated with 0.2%
agarose for 48 h at a density of 5×105 cells/ml in deﬁned serum-free
medium as described previously [20–23]. The medium was changed
every 2 days after plating on bacterial dishes. Eight days following
addition of RA, neuronal differentiation was completed, as conﬁrmed
by immunostaining against neuronal proteins NF-200, neuron-
speciﬁc enolase, and β-3-tubulin (data not shown). DifferentiatedP19 cell cultures were kept free from glial cells by treatment with
50 μg/ml cytosine arabinoside on the 6th day after induction of
differentiation [20–22].
2.3. Isolation and culture of sphere-derived cells from murine bone
marrow (MSCs)
All experiments were performed in accordance with the Animal
Protection Guidelines of the Federal University of Minas Gerais. Bone
marrow cells (MSCs) were collected from 2-month-old C57Bl/6 mice
bone marrow cells (MSCs) as previously described [13,24]. Femurs
and tibias frommice were ﬂushedwith complete medium constituted
of DMEM, 10% fetal calf serum (FCS, Sigma), 100 U/ml penicillin,
100 mg/ml streptomycin, 2 mM glutamine, and 5 U/ml heparin. Cells
were then plated at a density of 2×106 cells/cm2. Immunomagnetic
separation with Dynabeads, in accordance to the manufacturer's
protocol was used to separate differentiated hematopoietic cells.
Brieﬂy, primary rat anti-mouse antibodies, anti-CD8, CD11b, CD4,
CD45R/B220, Ter119, and Gr 1 (PharMingen, San Jose, CA), were used
to stain MSCs. Labeled cells were removed using Dynabeads M-450
Sheep anti-Rat IgG (Dynal Biotech, Oslo, Norway) with a Dynal
Magnetic Particle Concentrator (Dynal Biotech) by centrifugation. The
supernatant containing the lineage-depleted MSCs was then collect-
ed. Immunodepleted MSCs were resuspended in 10 ml of complete
medium and plated on a 35×10 mm tissue culture dish (NUNC,
Naperville, IL). Cells were cultured in a humidiﬁed incubator
containing 5% CO2 and 5% O2 at 37 °C for 24 h, non-adherent cells
were removed and fresh complete medium was added. Cells were
cultured until they reached 70–80% conﬂuency and then adherent
cells were detached with trypsin/EDTA and plated on 35×10 mm
standard tissue culture dishes.
2.4. MSC sphere formation and culture expansion
A total of 100,000 cells were suspended in complete medium on
dishes coated with 0.2% agarose. Suspended cells formed spheres and
gradually increased in size. Seven days after suspension, cells were
dissociated mechanically by gentle pipetting. Dissociated cells were
cultured in complete medium, which was changed every other day.
After reaching 40–50% conﬂuency, cells were detached with Trypsin/
EDTA and replated at a 1:4 dilution. Sphere-derived cells were
harvested for the experiments as described below when each well
contained more than 1×107 cells.
To induce neuronal differentiation, sphere-derived cells were
treated as previously described [13,24]. Brieﬂy, cells were plated at a
cell density of 1×104 cells/cm2 on gelatin-coated dishes in neurobasal
medium (Gibco BRL) with B27 Supplement (50×, Invitrogen), 20 ng/
ml EGF, and 10 ng/ml bFGF for 7 days, followed by culture in
neurobasal mediumwith 0.5 μM retinoic acid and 20 ng/ml β-NGF for
5 days.
Experiments were performed on control cultures the ﬁrst day after
plating. Pharmacological synchronization of cells in speciﬁc phases of
the cell cycle was started 24 h after plating, and cells were incubated
for a minimum of 12 h before experimental use.
2.5. Calcium oscillation analysis in CSC and MSC cells
CSC and MSC cells were loaded with Fluo3-AM by incubation with
4 μM Fluo3-AM in 0.5% Me2SO and 0.1% of the non-ionic surfactant
pluronic F-127 for 30 min at 37 °C in an extracellular medium
containing 140 mM NaCl, 3 mM KCl, 1 mM MgCl2, 2.5 mM CaCl2,
10 mMHEPES, and 10mMglucose at pH 7.4. After loading with Fluo3-
AM, cells were washed with incubation buffer and incubated for
20 min to ensure complete de-esteriﬁcation of Fluo3-AM. Ca2+
imaging was performed with an LSM 510 confocal microscope (Zeiss,
Jena, Germany) at 20–22 °C. Fluo3 was excited with a 488 nm line
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using a band pass ﬁlter. At the end of each experiment, 5 μM of the
ionophore 4-Br-A23187 followed by application of 10 mM EGTA were
used to determine maximal (Fmax) and minimal (Fmin) ﬂuorescence
values. Ca2+ concentration was calculated from the Fluo3 ﬂuores-
cence emission using a self-ratio equation as described previously
[13,20,21,25], assuming a Kd of 450 nM. The osmolarity of all the
solutions ranged between 298 and 303 mosmol/L. Calcium concen-
trations were calculated for cell populations of at least 10 cells in three
different experiments. Calcium oscillations from neural progenitor
cells derived from both CSCs and MSCs were measured 6 days after
the induction of neuronal differentiation. As we described previously
[13,20], at this time point 31% and 32% of cells were neural progenitor
cells, in CSCs and MSCs, respectively [13,20]. For measurements of
calcium oscillations in neural progenitor cells cell identity was
conﬁrmed with immunoﬂuorescence. Cells were incubated with
anti-nestin (Chemicon International Inc.) or anti-NEL (Santa Cruz
Biotechnology, Delaware, CA) antibody at 4 °C overnight. This was
followed by incubation with secondary antibodies coupled to
cytochrome 3 (Cy3, Jackson Immunoresearch) at room temperature
(RT) for 1 h. All calcium oscillation data from neural progenitor cells
are from cells that express nestin or NEL.
To evaluate the contribution of extracellular and intracellular Ca2+
mobilization to Ca2+ oscillations, the effects of various drugs were
studied. To study the inﬂuence of external calcium on calcium
oscillations, cells were treated with the extracellular calcium chelator
EGTA (1 mM). The effect of inhibitors of the sarcoplasmatic/
endoplasmatic reticulum Ca2+-ATPase (SERCA) such as cyclopiazonic
acid (CPA, 10 μM) [13,25] and 1 μM thapsigargin [26] on oscillations
were evaluated to study the role of depleting ER calcium on calcium
events. The inﬂuence of voltage-gated calcium channels (VGCC) on
oscillations was also studied. To this end, cells were exposed to the
VGCC blocker CdCl2 (100 μM) [27] and to the L-type calcium blocker
nifedipine (5 μM) [27,28] and an agonist of L-type channels Bay-K
(10 μM). In order to investigate the inﬂuence of store operated Ca2+
channels (SOCs) on calcium oscillations, the SOC inhibitor lanthanum
(50 μM) was used [29–31]. 2-Aminoethoxydiphenyl borate (2-APB,
10 μM), a cell permeant and reversible inhibitor of IP3R opening [32]
was used to study the involvement of IP3Rs on oscillations. Ryanodine
(10 μM; Rya InhC), which at this concentration act as an inhibitor of
RyR [33], was used to study the involvement of RyRs on calcium
oscillations. The effect of caffeine (10 mM) was also studied, for
caffeine at this concentration acts both as an inhibitor of the IP3R [34]
and as an activator of RyRs [35]. Various drugs were used to evaluate
the contribution of IP3Rs on calcium oscillations, such as U-73122
(5 μM), a phospholypase C inhibitor [36], and xestospongin C (XeC)
(1 μM), a membrane-permeable inhibitor of IP3 [28]. XeC at 1 μM only
affects the IP3R, but not the RyR, which has an IC50=22.6±2.2 μM
[37]).
To evaluate the contribution of extracellular and intracellular Ca2+
mobilization on cell growth rate and cell cycle progression, the effects
of 5 μM U-73122, a phospholypase C inhibitor and its biologically
inactive analog U-73343 (5 μM) [36] were evaluated. The effect of the
intra-cellular calcium chelator BAPTA-AM (10 μM) was also studied.
Growth rate and cell cycle analysis assays were also carried out in the
presence of thapsigargin (1 μM) [26], XeC (1 μM) [28], nifedipine
(5 μM) and lanthanum (50 μM), IP3R inﬂuence on cell growth was
studied by exposing cells to the reversible inhibitor of IP3R opening 2-
aminoethoxydiphenyl borate (2-APB, 10 μM) [32], the IP3R agonist
adenophostin-A (AdA) (2 nM) [38,39], and thimerosal (10 μM), a thiol
reagent described to increase the sensitivity of IP3R for its agonist [40].
2.6. Immunocytochemical analysis of the cell cycle
After recording calcium transients, a mark was made by a needle
around the cell on the slide (Lab-Tek). Cells were rapidly ﬁxed in−20 °C ethanol (75%) for 30 min and subsequently washed with and
incubated in phosphate-buffered solution containing 1 mg/ml bovine
serum albumin for 10 min at 25 °C. Double-labeled immunoﬂuores-
cence staining was carried out by incubation with monoclonal
antibodies against cell cycle-speciﬁc nuclear antigens (ﬂuorescein
isothiocyanate-conjugated anti-PCNA and R-phycoerythrin-conjugat-
ed Ki-67) for 30 min at 25 °C. Stained cells were observed under a
ﬂuorescencemicroscope (Axioskop, Zeiss) and photographed for later
analysis. PCNA expression varies throughout the cell cycle, as it has no
expression in the G0 phase, moderate expression in the G1 or G2 phase,
and maximal expression in the S phase. Ki-67 expression also differs
in different phases of the cell cycle, as it has no expression in the G0
phase, weak and aggregated expression in the G1 phase, increasing
expression in the S phase, and maximal expression in the G2 and M
phases. Thus, double staining with these two markers results in a
different nuclear ﬂuorescence color for each phase of the cell cycle.
Cells in G0 had no speciﬁc nuclear ﬂuorescence, whereas the cells in G1
showed green ﬂuorescence (PCNA) associated with aggregated spotty
red-orange ﬂuorescence (Ki-67). Cells in the M phase had red (Ki-67)
ﬂuorescence, and cells in the S phase emitted both red (Ki-67) and
green (PCNA) ﬂuorescence, thus giving them a yellow appearance.
Double staining coupled allowed to identify the cell cycle phase of the
cell enclosed by the mark made by the needle. Differential nuclear
staining was conﬁrmed in stem cells by arresting cells in the S or M
phase with aphidicolin and TN-16, respectively.
2.7. Cell cycle synchronization and detection by ﬂuorescence-activated
cell sorting
To synchronize CSCs andMSCs in the transition from G1 to S phase,
cells were incubated for 12 h with mimosine (MIM; 500 μM), an
inhibitor of the cell cycle which induces arrest in G1 by chelating iron
ions and inhibiting DNA replication in mammalian cells [41] or
hydroxyurea (HU; 2 mM), which blocks the synthesis of deoxynu-
cleotides inhibiting DNA synthesis, inducing synchronization in S-
phase [42]. In order to synchronize cells in the transition fromG2 toM,
cells were treated with demecolcine (DC; 20 ng/ml), which arrests
cells in metaphase [43]. Nocodazole (NOC; 100 ng/ml), was used to
arrest the cell cycle at G2/M phase, as this drug disrupts mitotic
spindles [44]. After 12 h, the cells were washed with EM and used for
Ca2+ imaging experiments within 2 h. Cell cycle distribution was
determined using a FACS Calibur ﬂow cytometer (Becton Dickinson,
San Jose, CA). Cells were washed with phosphate buffered saline and
incubated for 10 min in ice-cold ethanol (70%). After washing, cells
were treated with RNase (100 mg/million cells in PBS; 30 min at
37 °C). Propidium iodide (PI, 50 μg/ml)/RNase A staining buffer was
added for 60 min at 4 °C. PI ﬂuorescence was detected at 600 nm by
exciting at 488 nm. Data were acquired with Cell Quest software, and
the percentages of G1, S, and G2 phase cells were calculated with
MODFIT software.
2.8. RNA isolation, reverse transcription and real-time PCR
Total RNA was isolated using TRIzol (Invitrogen) from undiffer-
entiated CSC and MSC cells. Integrity of the isolated RNA was veriﬁed
by separation on a 2% ethidium bromide-stained agarose gel. DNAwas
removed from RNA samples by incubation with DNase I (Ambion Inc.,
Austin, TX). Primer sequences for reverse transcription and PCR
ampliﬁcation of β-actin, IP3Rs and RyRs isoforms mRNA are listed in
Table 1. Negative controls were treated with water and total RNA was
non-reverse transcribed. DNA templates were ampliﬁed by real time
PCR on the 7000 Sequence Detection System (ABI Prism, Applied
Biosystems, Foster City, CA, USA) using the Sybr green method
[20,21,45]. β-Actin was used as an internal control to normalize
variations in cDNA concentrations. Experiments were performed in
triplicate for each data point. After ampliﬁcation, electrophoresis of
Table 1
Primers for ampliﬁcation of InsP3Rs and RyRs receptors subtypes by real time PCR.
FWD = forward primer; REV = reverse primer.
Gene Access
number
Primer Sequence (5′–3′) Length
(bp)
qRT-PCR
IP3R1 NM_010585 FWD 5′ CTGCTGGCCATCGCACTT 3′ 66
REV 5′ CAGCCGGCAGAAAAACGA 3′
IP3R2 NM_019923 FWD 5′ AGCACATTACGGCGAATCCT 3′ 77
NM_0105868 REV 5′ CCTGACAGAGGTCCGTTCACA 3′
IP3R3 NM_080553 FWD 5′ CGGAGCGCTTCTTCAAGGT 3′ 75
REV 5′ TGACAGCGACCGTGGACTT 3′
RYR1 NM_009109 FWD 5′ AGACGCTACCACCGAGAAGAAC 3′ 83
REV 5′ TGGAAGGTGGTTGGGTCATC 3′
RYR2 NM_023868 FWD 5′ CCGCATCGACAAGGACAAA 3′ 76
REV 5′ TGAGGGCTTTTCCTGAGCAT 3′
RYR3 NM_177652 FWD 5′ CGCCTGAGCATGCCTGTT ′3 93
REV 5′ TTCTTGCATCTGTTTCCTTTTTTG 3′
β-Actin NM_007393 FWD 5′ GACGGCCAGGTCATCACTATTG 3′ 66
REV 5′ AGGAAGGCTGGAAAAGAGCC 3′
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product, Rockland, ME) was visualized under UV illumination after
staining with ethidium bromide.
2.9. Proliferation assays
To determine DNA synthesis rate, cells were exposed to 5-bromo-
2-deoxyuridine (BrdU; Amersham Life Sci). Twenty-four hours prior
to proliferation stimulation, undifferentiated and neural progenitor
cells from both CSC and MSCs were kept in serum-free deﬁned
medium. Cells were then maintained for 12 h in culture medium in
the absence or presence of the following drugs: U-73122 (5 μM) and
its biologically inactive analog U-73343 (5 μM) [36], BAPTA-AM
(10 μM), thapsigargin (1 μM) [26], 2-APB (10 μM) [32], XeC (1 μM)
[28], nifedipine (5 μM), lanthanum (50 μM), AdA (2 nM) [38,39], and
thimerosal (10 μM) [40]. BrdU (15 μM) was then added to the cell
culture for 60 min. BrdU labeling was monitored and used as a
measure for cell proliferation. To measure BrdU incorporation, cells
were incubated with an anti-BrdU monoclonal antibody (Roche
Applied Science, Indianapolis, IN) followed by incubation with
biotinylated goat anti-mouse IgG and avidin–biotin complex (Jackson
Immunoresearch; 1:200). Aminoethylcarbazole was used as a
chromogen for visualization of BrdU-positive cells. A more detailed
description of the method used can be found elsewhere [13,22].
For immunoﬂuorescence double-labeling experiments, embryonic
cells were ﬁxed in acidic alcohol and processed for nestin staining,
followed by BrdU incorporation and anti-BrdU staining. Cell prepara-
tions were then incubated with rabbit anti-nestin antibody (1:200;
Chemicon International Inc.) and immunoﬂuorescence was detected
in the presence of anti-rabbit IgG-Cy3 (Abcam, Cambridge, MA) or
IgG-Alexa-Fluor 488 (Molecular Probes, Eugene, OR) secondary
antibodies. Incubations were performed for 1 h at room temperature.
Nestin immunostaining was followed by incubation with 1 N HCl,
neutralization with 0.1 M sodium tetraborate and incubation with
Alexa Fluor 647-conjugated anti-BrdU (Molecular Probes) monoclo-
nal antibodies for 1 h at room temperature. After washing with
phosphate-buffered saline (PBS), BrdU/Nestin stained cells were
examined by ﬂuorescence microscopy.
2.10. Preparation of cytosolic and total membrane fractions
Cytosolic and total membrane fractions were prepared using a
slight modiﬁcation of the method reported by Mackman et al. [46].
Medium from undifferentiated and neural progenitor cells (NPCs)
from the 4th day of differentiation of CSCs andMSCswas removed and
replaced with serum-free DMEM including all the supplements
contained in the deﬁned medium for 12 h prior to the experiments.After removing the medium, cells were washed twice with ice-cold
PBS, scraped, harvested by microcentrifugation, and resuspended in
buffer A (137 mM NaCl, 8.1 mM Na2HPO4, 2.7 mM KCl, 1.5 mM
KH2PO4, 2.5 mM EDTA, 1 mM dithiothreitol, 0.1 mM phenylmethyl-
sulfonyl ﬂuoride, 10 μg/ml leupeptin, 0.5 mM sodium orthovanadate,
pH 7.5). Resuspended cells were then mechanically lysed on ice by
trituration with a gauge needle. Cell lysates were initially centrifuged
at 1000 × g for 10 min at 4 °C. Supernatants were collected and
centrifuged at 100,000 × g for 1 h at 4 °C to prepare the cytosolic and
total particulate fractions. The supernatant (cytosolic fraction) was
then precipitated with ﬁve volumes of acetone, incubated in ice for 5
min, and centrifuged at 20,000 × g for 20 min at 4 °C. The resulting
pellet was resuspended in buffer A, containing 1% (vol/vol) Triton X-
100. The particulate fractions containing the membrane fraction were
washed twice and resuspended in buffer A containing 1% (vol/vol)
Triton X-100. Protein levels were quantiﬁed using Bradford's
procedure [47].
2.11. Western blot analysis
Cells were harvested, washed twice with phosphate-buffered
saline, and exposed to lysing buffer (20 mM Tris [pH 7.5], 1 mM EDTA,
1 mM EGTA, 1% Triton X-100, 1 mg/ml aprotinin, 1 mM phenyl-
methylsulfonyl ﬂuoride, 0.5 mM sodium orthovanadate) for 30 min in
ice. The lysates were then cleared by centrifugation (10 min at
15,000 rpm, 4 °C), and protein concentration was determined using
the Bradford method [47]. Equal amounts of protein (20 μg) were
resolved by electrophoresis by 10% SDS-polyacrylamide gel electro-
phoresis and transferred to nitrocellulose membranes. Blots on
membranes were washed with TBST (10 mM Tris–HCl [pH 7.6],
150 mM NaCl, 0.05% Tween-20), blocked with 5% skim milk for 1 h,
and incubated with the appropriate primary antibody. Membranes
were then washed, and primary antibodies were detected with goat
anti-rabbit IgG or goat anti-mouse IgG conjugated to horseradish
peroxidase. The bands were then visualized by enhanced chemilumi-
nescence (Amersham Pharmacia Biotech).
2.12. Immunoprecipitation and kinase assays
Cells were extracted for 30 min in ice-cold lysis buffer (0.1 mM
dithiothreitol, 8 mM β-glycerophosphate, 1 mM ethylenediaminete-
traacetic acid, 150 mM sodium chloride, 50 mM sodium ﬂuoride, 0.5%
Nonidet P-40, 50 mM Tris–HCl (pH 7.4), 1 μg/ml aprotinin, 100 mM
phenylmethylsulphonyl ﬂuoride (PMSF), 10 μg/ml soybean trypsin
inhibitor, 10 μg/ml tosylphenylalanine chloromethane, 1 μg/ml
leupeptin), and further processed as described previously [13,22].
Brieﬂy, extracts were cleared by centrifugation at 15,000 × g for 5 min
at 4 °C and stored at −80 °C until use. After thawing, protein
concentration was determined using a DC protein assay kit (Bio-Rad).
Extracts were incubated with the appropriate antibodies for 1 h in ice.
Immunoprecipitates were collected on Protein G agarose beads by
overnight rotation, washed four times with lysis buffer, re-suspended
in 2× Laemmli sample buffer, and subjected to SDS-PAGE followed by
Western blot analysis. To control for the speciﬁcity of the immuno-
precipitation reaction, a control sample containing only cell lysate and
G protein-coupled beads, but no antibody, was included in each set of
immunoprecipitated samples (no antibody control). For kinase
assays, immunoprecipitates were prepared as above, except that the
last two washes were performed using kinase assay buffer (50 mm N-
(2-hydroxyethyl) piperazine-N′-(2-ethanesulfonic) acid (HEPES), pH
7.5; 8 mM β-glycerophosphate; 1 mM dithiothreitol; 10 mM MnCl2;
10mMMgCl2). For CDK2, kinase reactions were carried out for 30min
at 37 °C in a total volume of 25 μl in kinase assay buffer supplemented
with 100 μg/ml histone H1 (type III-S) and 40 μCi/ml [32P]ATP. For
CDK4, kinase reactions were carried out for 30 min at 30 °C in a total
volume of 25 μl in kinase assay buffer supplemented with 160 μg/ml
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samples of kinase reactions no antibody control and substrate control
were used. Reactions were terminated by addition of 2× Laemmli
sample buffer. Each reaction mix was then subjected to SDS-PAGE.
Autoradiographies of gels and bands were quantiﬁed on a Molecular
Dynamics PhosphorImager plate.
2.13. Statistical analysis
Data are presented as means±S.E.M. of ﬁve or more independent
experiments, each with two replicates. Statistical signiﬁcance was
determined by Student's t-test or one-way ANOVA plus a post-hoc
Tukey's test. Values of pb0.05 were considered as statistically
signiﬁcant.
3. Results
3.1. Spontaneous Ca2+ oscillations are restricted to the G1/S phase
transition during neuronal differentiation of CSCs and MSCs
To study neuronal differentiation in embryonic (CSCs) and somatic
(MSCs) stem cell lines and the role of calcium events in this process,
we monitored the occurrence of calcium oscillations in undifferenti-
ated cells and differentiated neural progenitor cells (NPCs). Sponta-
neous Ca2+ oscillations were present in 37% and 64% of
undifferentiated CSCs and MSCs, respectively. During neuronal
differentiation, the number of oscillating cells did not change.
However, there were signiﬁcant differences in amplitude, as NPCs
had higher amplitude calcium events than undifferentiated cells
(Supplementary Fig. 1). To determine if these spontaneous Ca2+
events vary throughout the cell cycle, we synchronized cells at distinct
phases of the cell cycle and analyzed their Ca2+ oscillations. Cell cycle
distributions were obtained by analyzing histograms of cells stained
with propidium iodide and separated through ﬂuorescence-activated
cell sorting (FACS).
Undifferentiated cells were synchronized at the G1/S transition
with mimosine (MIM, 500 μM), an iron chelator that inhibits DNA
replication in mammalian cells [41,48]. To study cells in the G2/M
transition, cells were incubated with demecolcine (DC, 20 ng/ml), a
substance that depolymerizes microtubules, blocking mitosis at
metaphase. FACS analysis of PI-stained MIM- and DC-treated cultures
revealed a shift of the cell cycle distribution from control conditions.
In CSC andMSCMIM-treated cultures, themajority of cells were in G1,
in both NPCs and undifferentiated cells, whereas in DC-treated
cultures, cells accumulated in the G2/M transition (Fig. 1). This
demonstrates that we successfully arrested the cell cycle in the G1/SFig. 1. Pharmacologically induced changes of cell cycle distribution in undifferentiated and n
Bar graph shows the cell cycle distribution of three independent experiments analyzed usi
of the percentage of cells that reside in the G0/G1, S, or G2/M phases of the cell cycle in
(DC, 20 ng/ml), nocodazole (NOC, 100 ng/ml) or hydroxyurea (HU, 2 mM). Data are preseand in the G2/M transitions, respectively, withMIM and DC (Fig. 1), as
shown previously [13,17,22,49–51].
The number of cells with spontaneous Ca2+ oscillations after
treatment withMIM increased in both undifferentiated cells and NPCs
from CSCs and MSCs (Table 2). Moreover, these increases were
correlated with the total number of cells synchronized in the G1 phase
of the cell cycle (Fig. 1). In undifferentiated cells and NPCs treated
with DC, only a low percentage of cells within individual colonies had
spontaneous Ca2+ oscillations. Interestingly, the number of cells with
such oscillations correlated with the number of cells in G1 (Fig. 1). We
also used other cell cycle inhibitors (HU and NOC) to verify if the shift
in the total number of cells presenting spontaneous Ca2+ oscillations
was due to a reaction to DC andMIM that is unrelated to control of the
cell cycle (Fig. 1).
To synchronize cells in the G1/S transition, we used 2 mM
hydroxyurea (HU), a drug that arrests cells in the S phase by blocking
deoxynucleotides synthesis [42]. In order to arrest the cells in the
transition from G2 to M, cells were incubated with NOC (100 ng/ml), a
drug that disrupts mitotic spindles [44,48]. Treatment with HU and NOC
inducedeffects thatwere similar to exposure toMIMandDC, respectively
(Fig. 1). Thus, different drugs that arrest the cell cycle in the same
transition points produced similar results. This strongly suggests that the
observed increase in the fractionofG1 cellsdisplaying calciumoscillations
is indeed due to arrest in the G1/S transition. Importantly, the frequency
and amplitude of Ca2+oscillations did not differ between control andG1/
S synchronized cells (Supplementary Fig. 1).
These results show that cells displaying calcium oscillations are
primarily in G1/S. Moreover, these data indicate that while the
fraction of cells displaying calcium oscillations is modulated through-
out the cell cycle, the frequency and amplitude of these events are not.
Strikingly, the same results were found in NPCs and undifferentiated
cells derived from two different lineages, suggesting that this event
may be conserved across lineages.
3.2. Maintenance of Ca2+ oscillations
Intracellular Ca2+ concentration ([Ca2+]i) is controlled by multiple
mechanisms that regulate Ca2+ inﬂux from internal and external
sources. Increases in intracellular Ca2+ due to release from the
endoplasmic reticulum (ER) is controlled by RyRs [35] and IP3Rs [50].
This activity is counter-balanced by Ca2+ pumps, such as the Sarco/
Endoplasmic Reticulum Ca2+-ATPase (SERCA) [51]. Calcium inﬂux from
external sources canbemediatedbyvoltage-gated calciumchannels and
store-operated calcium channels (SOCs) [52,53]. We studied the
inﬂuence of calcium inﬂux from both external and internal sources in
the spontaneous Ca2+ oscillations observed in the G1/S transition.eural progenitor cells of carcinoma stem cells (CSC) andmesenchymal stem cells (MSC).
ng ﬂuorescence-activated cell sorting (FACS). The graph allows the direct comparison
control conditions and after treatment with mimosine (MIM, 500 μM), demecolcine
nted as means from three independent experiments.
Table 2
Percentage of oscillating cells in control and after mimosine (MIM, arrests cells in G1
phase), demecolcine (DC, arrests cells in metaphase), hydroxyurea (HU, synchronize
cells in S-phase), or nocodazole (NOC, arrest the cell cycle at G2/M phase) treatment,
respectively, for neuronal progenitor cells from carcinoma (CSC) and mesenchymal
(MSC) stem cells.
% of Undifferentiated Neural progenitor cells
oscillating cells
CSC MSC CSC MSC
Control 23.1±6.2 53.8±8.3 30.6±6.8 56.1±5.4
MIM 60.8±12.5⁎⁎ 92.1±11.6⁎ 71.4±10.3⁎⁎ 75.8±8.2⁎
HU 65.7±10.7⁎⁎ 89.6±9.2⁎ 67.6±8.5⁎ 69.8±7.5
DC 9.6±8.2⁎ 13.4±9.1⁎⁎ 12.5±9.8⁎⁎ 17.2±5.9⁎⁎
NOC 6.2±4.4⁎ 8.6±7.4⁎⁎ 5.9±4.2⁎⁎ 8.0±7.9⁎⁎
Mimosine (MIM; 500 μM); demecolcine (DC; 20 ng/ml); nocodazole (NOC; 100 ng/ml),
and hydroxyurea (HU; 2 mM). Data presented are means±S.E.M. ⁎pb0.05, ⁎⁎pb0.001
relative to control conditions.
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evaluated by treating cells with the SERCA inhibitor cyclopiazonic acid
(CPA). CPA depletes intracellular calcium stores, thus abolishing the
contribution of these stores to the observed oscillations. Interestingly,
calcium oscillations were undetectable in undifferentiated cells
exposed to CPA. However, in NPCs CPA had a less drastic effect, onlyFig. 2. Characterization of spontaneous Ca2+ oscillations in undifferentiated and neural proge
control cultures (black traces) and mimosine-treated (MIM, 500 μM) cells (dashed gray tra
transients in undifferentiated cells, but only decreases their amplitude in NPCs. Similar obs
showing average changes in amplitude (left panel) and frequency (right panel) of calcium os
experiment was 20–26.reducing the amplitude and frequency of the oscillations (Fig. 2 and
Supplementary Fig. 2). This result suggests that internal calcium
stores are required to produce these calcium events in undifferenti-
ated cells, while NPCs can maintain them through other mechanisms,
such as by activation of voltage gated calcium channels [10,21,54]. To
evaluate if extracellular Ca2+ stores participate in spontaneous Ca2+
oscillations in undifferentiated cells and NPCs we exposed cells in the
presence and absence of MIM to a Ca2+-free extracellular solution,
which was obtained by adding the calcium chelator EGTA. Interest-
ingly, the amplitude and frequency of Ca2+ oscillations were reduced,
but less robustly than in CPA-treated cells (Fig. 2 and Supplementary
Fig. 2). These results show that while external calcium may inﬂuence
the amplitude and frequency of these oscillations, presumably
because they may be necessary to replenish intracellular stores.
To characterize the contribution of external calcium stores we sought
to identify which channels mediate the inﬂux of external calcium
necessary tomaintainCa2+oscillations. To this end, cellswere exposed to
the SOC inhibitor lanthanum (50 μM), and the L-type Ca2+ channel
inhibitor, nifedipine (5 μM). Interestingly, inhibition of L-type calcium
channels and SOCs abolished calcium events in undifferentiated cells and
NPCs (Fig. 3 and Supplementary Fig. 3). It is noteworthy that these results
were conducted in the presence of thapsigargin, a drug that inhibits the
ER SERCA pump, abolishing the contribution of internal stores to thenitor cells derived fromMSCs. (A) Representative traces showing calcium oscillations in
ces). Note that the SERCA inhibitor cyclopiazonic acid (CPA, 100 μM) abolishes calcium
ervations were obtained in four different experiments for each line cell. (B) Bar graphs
cillations in cells treated with EGTA and CPA. The total number of cells analyzed in each
Fig. 3. Involvement of L-type calcium channels and through store-operated Ca2+ (SOC) channels in spontaneous Ca2+ oscillations. (A) Ca2+ measurements in a single
undifferentiated (Und) or neural progenitor cells (NPC) from mesenchymal stem cells (MSC), respectively, in non-treated (black traces) and mimosine (MIM; 500 μM) treated
cultures (dashed gray traces). Changes in [Ca2+]i during store depletion with the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (Thaps, 1 μM) in the absence (1 mM
EGTA) and presence of [Ca2+]o (2.5 mM Ca2+) and during superfusion with the SOC inhibitor lanthanum (La3+, 50 μM), and the L-type Ca2+ channel inhibitor, nifedipine (5 μM).
Inhibition of L-type calcium channels and SOCs abolished calcium events in undifferentiated cells and NPCs. La3+ reversibly blocked about 81% of the Ca2+-entry induced by
depletion of the intracellular Ca2+ stores. (B) Bar graphs showing average changes in amplitude (left panel) and frequency (right panel) of calcium oscillations in cells treated with
nifedipine and La3+. Data are presented as means±(SD). n=38–47 cells for each experiment.
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inﬂux. These data show that L-type channels and SOCs are involved in the
generation of calcium events in undifferentiated cells and in NPCs.
We next investigated whether replenishment of internal Ca2+
stores through SOCs contribute to Ca2+ oscillations. Previous data
have shown that SOCs are present in mesenchymal and embryonic
stem cells [10,11], raising the possibility that these channels may
contribute to the calcium oscillations observed here. To determine if
SOCs contribute to the replenishment of intracellular Ca2+ stores we
exposed cells to a Ca2+-free solution in the presence of thapsigargin, a
Ca2+-ATPase (SERCA) inhibitor. Thapsigargin induced a transient
increase in internal Ca2+ due to the uncompensated release of Ca2+
from intracellular stores. As depletion of intracellular stores triggers
calcium inﬂux through SOCs, it is likely that the observed increase in
calcium oscillations following the addition of Ca2+ (2.5 mM) is due to
SOC opening (Fig. 3 and Supplementary Fig. 3). This result indicates
that replenishment of intracellular Ca2+ stores in CSC and MSC cells is
mediated by inﬂux of extracellular Ca2+ through SOCs. However,
extracellular Ca2+ is not required for the induction of Ca2+
oscillations, as they are still observed in the absence of extracellular
calcium (see the ﬁrst 500 s of the traces shown in Fig. 3A).
3.3. Spontaneous Ca2+ oscillations are regulated by IP3Rs in
undifferentiated cells and by IP3Rs and RyRs in neural progenitor cells
We also analyzed the contribution of internal calcium stores to
calcium oscillations. RyR mRNA was observed after, but not beforeinduction of neuronal differentiation (Supplementary Fig. 6), as
previously described [13,55]. The ER channel IP3R, on the other
hand, was present during all developmental stages of stem cells
(Supplementary Fig. 6) [13,55]. To determine which channelsmediate
spontaneous Ca2+ oscillations in undifferentiated stem cells and NPCs
we exposed cell cultures to the IP3R antagonist 2-APB (10 μM), or to
ryanodine (10 μM), which in this concentration acts as a RyR
antagonist [33]. Calcium transients were abolished in undifferentiated
cells treated with IP3R inhibitors, such as 2-APB, U-73122 or
xestopongin C (Fig. 4 and Supplementary Fig. 4). On the other hand,
exposure to the RyR inhibitor ryanodine (10 μM) in undifferentiated
cells did not block spontaneous Ca2+ oscillations and no difference in
oscillation frequency or amplitude was found (Fig. 4 and Supplemen-
tary Fig. 4). To conﬁrm the result, we treated undifferentiated cells
with the RyR agonist and IP3R inhibitor caffeine (10 mM). Undiffer-
entiated cells treated with caffeine did not display calcium oscillations
as previously demonstrated (Fig. 4 and Supplementary Fig. 4) [13,55].
Conversely, in NPCs, caffeine (10 mM) caused a transient peak in
calcium (Fig. 4 and Supplementary Fig. 4) that is attributable to a
caffeine-induced release from ryanodine-sensitive stores, indicating the
involvement of RyRs in calcium oscillations in NPCs. The subsequent
depression of [Ca2+]i can be either due to suppression IP3Rs [56–59] or
to depletion of ryanodine-sensitive calcium stores [59,60].
Consistent with a role for RyRs in calcium events in NPCs, treatment
with ryanodine (10 μM) reduced the amplitude and frequency of Ca2+
oscillations (Fig. 4 and Supplementary Fig. 4). Unlike in undifferentiated
cells, oscillations in NPCs were reduced, but not abolished by the IP3R
Fig. 4. Spontaneous Ca2+oscillations require inositol 1,4,5-trisphosphate receptor (IP3R)-mediatedCa2+release. (A)Upper panels: Representative recordings of [Ca2+]iwithin a single cell
during superfusionwith the IP3R antagonist 2-aminoethoxydiphenylborate (2-APB, 10μM),orwithRyanodine (Rya InhC, 10 μM),which at this concentration acts as a RyRantagonist. Cells
were also treated with caffeine (10 mM), which in this concentration inhibits IP3Rs and activates ryanodine receptors. Cells were also exposed to the phospholipase C (PLC) inhibitor U-
73122 (5μM). IP3R-mediatedCa2+oscillations innon-treatedandmimosine (MIM;500 μM)treatedcultures fromundifferentiatedandneural progenitor cells (NPC)ofmesenchymal stem
cells (MSC), respectively. Lower panels: Representative recordings of [Ca2+]i showing the effect of xestopongin-C in calcium oscillations of undifferentiated (left) andNPCs (right) derived
fromMSCs. The total number of cells analyzed in each experiment was 45–58. (A, lower panels) Representative recordings of [Ca2+]i within a single cell during superfusion with the IP3R
antagonist xestospongin C, which abolished spontaneous oscillations of [Ca2+]i in undifferentiated and decreased their amplitude in neural progenitor cells from MSCs. (B) Bar graphs
showing average changes in amplitude (left panel) and frequency (right panel) of calcium oscillations in cells treated with the drugs shown in (A). Data are presented as means±(SD).
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oscillations throughmechanisms independent of IP3R signaling, such as
RyR-mediated Ca2+ release [13,21,54,61].
Thus, the ﬁnding that Ca2+ transients were abolished in undiffer-
entiated cells in the presence of caffeine suggests that IP3Rs, but not
RyRs, are required for maintaining these oscillations. Application of 2-
APB resulted in a reversible inhibition of Ca2+ oscillations, indicating a
contribution from IP3-sensitive stores and SOCs (Fig. 4 and Supple-
mentary Fig. 4). The same results were found when cells were treated
with U-73122, a drug that decreases IP3R signaling by inhibiting PLC-
mediatedproduction of IP3. Cellswere also treatedwith themembrane-
permeable inhibitor of IP3Rs, Xestospongin C (XeC). Cells were treated
withU-73122 andXeCbecause the effect observedwith 2-APB could bedue to its effect on gap junctions and SOCs [62–64]. Spontaneous
oscillations were also decreased by U-73122, XeC and caffeine in both
undifferentiated and NPCs from CSC and MSC cells. Our data
consistently indicate that in both CSCs and MSCs, spontaneous
oscillations in undifferentiated cells depend on the release of Ca2+
from IP3R-regulated intracellular stores, while in NPCs, both RyRs and
IP3Rs contribute to these oscillations (Fig. 4 and Supplementary Fig. 4).
3.4. Role of spontaneous Ca2+ events in cell cycle progression and
cell proliferation
It has been reported that cell cycle progression occurs synchro-
nously with spontaneous Ca2+ events [17,65,66]. These events can be
Table 3
Cell cycle progression of undifferentiated carcinoma (CSC) andmesenchymal stem cells
(MSC) cultures.
Growth rate Undifferentiated
(in hours)
CSC MSC
Control 18.1±0.5 28.8±1.0
U-73343 18.7±1.4 28.6±0.7
U-73122 23.0±1.3⁎ 36.9±1.7⁎
BAPTA-AM 27.1±2.1⁎⁎ 42.8±2.7⁎⁎
Thapsigargin 26.4±1.1⁎⁎ 40.5±2.3⁎⁎
2-APB 22.0±1.2⁎ 38.2±1.8⁎⁎
Xestopongin C 21.7±1.5⁎ 39.5±1.2⁎⁎
Nifedipine 20.1±2.1⁎ 33.6±1.3⁎
Lanthanum 19.5±1.8⁎ 33.4±2.3⁎
AdA 13.3±0.1⁎⁎ 22.2±0.7⁎⁎
Thimerosal 14.0±0.1⁎⁎ 21.1±0.6⁎⁎
U-73343 (5 μM), U-73122 (5 μM), BAPTA-AM (10 μM), thapsigargin (1 μM), 2-
aminoethoxydiphenyl borate (2-APB, 10 μM), Xestopongin C (10 μM), nifedipine
(5 μM), lanthanum (100 μM), adenophostin-A (AdA, 2 nM), thimerosal (10 μM). Data
presented are means±S.E.M. ⁎pb0.05, ⁎⁎pb0.001 relative to control conditions.
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further studied the role of intracellular calcium dynamics in this
process in undifferentiated cells and NPCs, derived from CSCs and
MSCs. To this end, we determined the proliferation rate of cells treated
with the PLC-β blocker U-73122 (5 μM) and the intracellular Ca2+
chelator BAPTA-AM (10 μM). Treatment with these drugs signiﬁcantly
decreased rates of proliferation (Fig. 5 and Table 3). Importantly, U-
73343, a structural analog of U-73122 that does not inhibit PLC-β
activity, did not affect growth rates (Fig. 5A, B). Cells were also treated
with 2-APB (10 μM), xestospongin C (XeC, 1 μM), and thapsigargin
(1 μM) to evaluate the growth rate of undifferentiated CSCs andMSCs.
Blocking calcium oscillations by decreasing IP3R activation with XeC
and 2-APB induced a signiﬁcant slowing in cell cycle progression
(Fig. 5A, B). Additional studies were carried out to elucidate if
promotion of calcium oscillations through activation of IP3Rs affect
the rate of proliferation in CSCs and MSCs. Cells were treated with
either AdA (2 nM), an IP3R agonist, or thimerosal (10 μM), a thiol
reagent described to increase the sensitivity of IP3R for its agonist.
Both induced an increase in the rate of proliferation of undifferenti-
ated CSCs and MSCs (Fig. 5A, B). These results suggest the
involvement of PLC-β and IP3-induced release of Ca2+ from internal
stores in signaling pathways leading to proliferation. Similar results
were obtained with BrdU incorporation assays (Fig. 5C), showing that
the results in Fig. 5A and B are due to increased proliferation, and not
thus cannot be attributed to a decrease in cell death.Fig. 5. IP3R activation increases cell proliferation. Curves show proliferation of CSCs (A)
thapsigargin, 10 μM 2-aminoethoxydiphenyl borate (2-APB), 1 μM Xestospongin C, 5 μM ni
graphs showing % of BrdU-positive cells in cultures exposed to the same drugs used in (A
normalized changes from control cultures, and are presented as mean values±S.E.M.; ⁎pb0.
conﬁrmed using the chi-square test: pb0.005. n=4–6 for each drug treatment.Strikingly, exposure to drugs that decrease calcium oscillations,
such as U-73122, 2-APB, lanthanum, nifedipine or BAPTA-AM
decreased the number of cells in G2/M but increased the number of
cells in the G1 and S phases, both in undifferentiated cells and NPCs
(Fig. 6). Conversely, exposure to the RyR agonist ryanodine (1 μM), orand MSCs (B) treated with 5 μM U-73343, 5 μM U-73122, 10 μM BAPTA-AM, 1 μM
fedipine, 50 μM lanthanum, 2 nM adenophostin-A (AdA) or 10 μM thimerosal. (C) Bar
), for undifferentiated cells (left panel) and NPCs (right panel). Data are presented as
001 compared with control data. Signiﬁcance of the change in cell cycle distribution was
Fig. 6. IP3R activation shifts the cell cycle distribution toward the G2/M transition phase of the cell cycle. Undifferentiated cells and NPCs were treated with 5 μM U-73343, 5 μM U-
73122, 10 μM BAPTA-AM, 1 μM thapsigargin, 10 μM 2-aminoethoxydiphenyl borate (2-APB), 1 μMXestospongin C, 5 μMnifedipine, 50 μM lanthanum (n=3), 2 nM adenophostin-A
(AdA), 10 μM thimerosal compared to the control cells. NPC cultures were also treatedwith ryanodine 1 μM. Data are presented as normalized changes from control cultures. Data are
presented as mean values±S.E.M.; ⁎pb0.05, ⁎⁎pb0.001 compared with control data. Signiﬁcance of the change in cell cycle distribution was conﬁrmed using the chi-square test:
Pb0.005). n=3–5 for each drug treatment.
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cells in G2/M (Fig. 6). To characterize the participation of extracellular
Ca2+ stores on cell cycle progression we used nifedipine, an L-type
calcium channel blocker, and lanthanum, a SOC inhibitor. Both
nifedipine and lanthanum induced a signiﬁcant increase on cell
turnover time (Fig. 5 and Table 3).
These data indicate that PLC-mediated Ca2+ oscillations may play
an important role in cell cycle progression through the G1/S phase in
undifferentiated CSC and MSC cells.
3.5. Involvement of IP3R-induced signaling in cyclin expression
We showed that decreasing calcium oscillations by blocking IP3R
responses reduced the number of cells residing in G2/M and the rate
of proliferation of undifferentiated cells and NPCs (Fig. 5C). This result
suggests that the expression of cell cycle regulators, such as cyclin D1
may be affected by altered IP3R signaling. To further study this issue
we studied the effects of treating cells with the purinergic receptor
agonist ATP, as ATP induces calcium transients mediated by IP3R
activation [20,49]. ATP was found to increase levels of proteins that
are highly expressed in proliferating cells, such as cyclin D1, cyclin E,
CDK2, and CDK4 (Fig. 7 and Supplementary Fig. 5). Conversely, the
opposite effect was found when cells were exposed to drugs that
suppress calcium waves, such as the IP3R pathway inhibitors 2-APB,
xestospongin C, wortmanin, and PD 98059 (Fig. 7 and SupplementaryFig. 5). These results were observed with undifferentiated cells and
NPCs derived from both CSCs and MSCs. To verify if IP3R was indeed
the calcium channel that mediated the effects observed on progres-
sion of the cell cycle, we treated NPCs with antagonists of other
calcium channels, such as thapsigargin, lanthanum, and ryanodine at
inhibitory concentrations (10 μM) in the presence or absence of ATP,
and evaluated their effect on cyclin expression. Treatment with
thapsigargin alone and in the presence of ATP, decreased and
maintained similar to the control, respectively, protein levels of cyclin
D1, cyclin E, CDK2, and CDK4. Conversely, when NPCs were treated
with lanthanum and ryanodine (10 μM) no effect on protein levels
was observed. Although, when NPCs were treated with the same
drugs in the presence of ATP protein levels presented a signiﬁcant
increase when compared to control conditions. Furthermore, when
NPCs were treated with U-73122 alone, cell cycle protein levels were
reduced beyond control levels (Fig. 7C), indicating that IP3Rs were
responsible for the observed effect on progression of the cell cycle
(Fig. 6).
3.6. Cell cycle kinase activity during MSC neuronal differentiation
The eukaryotic cell cycle is regulated primarily by a family of
serine/threonine protein kinases, consisting of regulatory cyclin
subunits and catalytic cyclin-dependent kinase (Cdk) subunits (for
review see [68,69]). In mammalian cells, complexes of Cdk4 and
Fig. 7. Inhibition of IP3Rs decreases protein levels of cell cycle regulators. Mesenchymal stem cells (MSC) were treated with adenophostin-A (2 nM, AdA) for periods between 1 and
30 h (A), or pretreated with 2-APB (10 μM), Xestospongin C (1 μM), wortmannin (1 μM), or PD 98059 (1 μM) for 30 min prior to incubating the cells with AdA (2 nM) for 3 h (B).
Additional studies were performed on neural progenitor cells (NPCs). NPCs were treated for 30 min with ATP in the presence or absence of thapsigargin (Thaps, 1 μM), lanthanum
(50 μM), ryanodine (10 μM), and U-73122 (5 μM) (C). The total lysates were then subjected to SDS-polyacrylamide gel electrophoresis and blottedwith the cyclin D1, cyclin E, cyclin-
dependent kinase 2 (CDK2), or CDK4 antibody. Each example shown (left panels) is representative of three experiments. Right panels (bar graphs) denote themean±S.E.M. of three
experiments for each condition determined from densitometry relative to β-actin. ⁎pb0.05 versus control; #pb0.001 versus AdA alone.
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the G1 restriction point, while Cdk2/cyclin E complexes are required
for the G1 to S transition. Complexes of Cdk2-cyclin A function are
involved in the progression of cells through S phase [70]. This
process is negatively regulated by p27, as this protein binds to the
cyclin E–Cdk2 complex, resulting in inhibition of its kinase activity
[71,72]. If IP3R-induced calcium oscillations promote proliferation,
lower binding of cyclins E and A to p27 would be expected in cells
treated with IP3R agonists. In line with a role for calcium oscillations
in proliferation, cells treated with the IP3R agonist AdA had lowerlevels of Cyclin E and A bound to p27, as found through co-
immunoprecipitation assays (Fig. 8). This result suggests that IP3R
signaling acts to increase proliferation by removing p27-mediated
inhibition.
We also investigated the inﬂuence of IP3R signaling on cell cycle
regulatory proteins during neuronal differentiation. To this end,
differentiating MSCs were treated with the IP3R agonist AdA or with
the IP3R antagonist xestopongin C. Treatment with AdA increased
levels of cyclins A and E, as found by both western blots and cyclin
kinase activity (Fig. 7A and B). These results show that proliferation is
Fig. 8. IP3R activation upregulates kinase activity of cyclins A and E and CDK2 and decreases their binding to the negative regulator p27 (A) Undifferentiated mesenchymal stem cells
(MSCs), were treated with adenophostin A (AdA, 2 nM), an agonist for IP3Rs, or Xestospongin C (XeC, 1 μM), a membrane permeable inhibitor of IP3Rs). Cultures were lysed and used
to immunoprecipitate cyclin A, cyclin E, CDK2 and p27. Kinase activity towards histone H1 in cyclin- and CDK2-immunoprecipitates was determined by autoradiography. Three
independent replicates were quantiﬁed by densitometry. Graphs represent means±SDs of autoradiographic signal normalized to control conditions. (B) Levels of p27 in cyclin A,
cyclin E and CDK2 were determined by Western blotting, normalized to β-actin levels. Data are representative of three independent replicates. (C) Quantiﬁcation of levels of
complexes of p27 with cyclin A, cyclin E and CDK2 through immunoprecipitation in cultures treated with AdA and XeC. ⁎pb0.05 versus control; ⁎⁎pb0.001 versus control; #pb0.05
versus AdA-treatment; #pb0.001 versus AdA-treatment.
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antagonists, while IP3R agonists have the opposite effect. Further-
more, exposure to lanthanum and ryanodine (10 μM) do not change
cyclin expression (Fig. 7C), consistent with the view that IP3R, but not
RyR activation modulates progression of the cell cycle. On the other
hand, thapsigargin decreases cyclin expression (Fig. 7C). As thapsi-
gargin depletes ER calcium stores, it is likely that the effect of
thapsigargin on cyclin expression is mediated by disruption of IP3R
signaling.
4. Discussion
Cell cycle progression in stem cells and neural progenitor cells
controls proliferation of neurons and glia during development of the
central nervous system. Here we have demonstrated that in
embryonic CSCs and adult MSCs cell cycle progression through the
G1/S transition is accompanied by spontaneous oscillations of [Ca2+]i.
These Ca2+ oscillations are regulated by IP3Rs and RyRs in NPCs, while
in undifferentiated stem cells IP3Rs, but not RyRs, appear to regulate
these events. Our data also shows that inhibition of IP3R pathways in
undifferentiated cells impede progression of the cell cycle, possibly
due to downregulation of cyclins A, D1 and E. Furthermore, activation
of IP3Rs increases cell proliferation. These data raise the possibility
that control of calcium oscillations by IP3Rs may play a role in cell
cycle progression and cell proliferation.4.1. Spontaneous Ca2+ oscillations in embryonic CSC and adult MSC
We have demonstrated that undifferentiated cells and NPCs from
embryonic CSCs and adult MSCs display spontaneous Ca2+ oscillations
(Fig. 2 andSupplementary Fig. 2), as in previous reports [13]. Thepresent
work shows that while the ER is the major source of Ca2+ for these
oscillations, extracellular Ca2+ inﬂux from SOCs is required to sustain
these oscillations, presumably to reﬁll intracellular stores of Ca2+.
Interestingly, these oscillations tend to occur at the G1/S transition,
suggesting a role for calcium events in control of cell cycle progression.
ER intracellular Ca2+ stores are regulated by two families of
receptors: IP3Rs and RyRs [52,73]. Cytosolic IP3 may be responsible for
these Ca2+ oscillations (Fig. 4 and Supplementary Fig. 4), as suggested
previously [13,74]. Interestingly, previous work has demonstrated
that [Ca2+]i changes can be induced by IP3 oscillations through
dynamic and rapid uncoupling of IP3Rs [75], in line with our results. In
both undifferentiated cells and NPCs, IP3Rs regulate Ca2+ oscillations,
whereas in later stages of differentiation both IP3Rs and RyRs
contributed to these events, consistent with previous work [13].
4.2. Involvement of IP3R-induced Ca
2+ oscillations in cell
cycle progression
Some studies have demonstrated a role for IP3 signaling pathways
[78,79] and for IP3-mediated Ca2+ release [17] in progression of the
258 R.R. Resende et al. / Biochimica et Biophysica Acta 1803 (2010) 246–260cell cycle in embryonic stem cells. In line with these previous reports,
our data show that in undifferentiated cells and NPCs from CSCs and
MSCs proliferation was signiﬁcantly decreased in the presence of
drugs that prevent rises in [Ca2+]i through PLC- and IP3-mediated
pathways (Figs. 5–8). These results are in good agreement with a
recent report indicating that EGF stimulates proliferation of mouse
embryonic stem cells via PLC-dependent changes in [Ca2+]i [80].
Furthermore, we have previously shown that neurogenesis induced
by cholinergic [21,22,81] and purinergic receptors [49] is mediated by
IP3Rs [13]. Thus, a role for IP3R signaling in the maintenance of
calcium oscillations is strongly supported by both by the current work
and previous reports.
Interestingly, we found that expression levels of cell cycle
regulatory proteins (cyclin D1, cyclin E, CDK2, and CDK4) were
dependent on IP3-mediated pathways. This suggests that IP3 induces
cell cycle progression beyond the G1 phase of the cell cycle. These
results also indicate that once IP3Rs are activated, PKC transmits
signals to the nucleus through one or more MAPK cascades and
activates immediate early genes. Therefore, the present results show
that IP3modulates proliferation, possibly due to its role inmaintaining
calcium oscillations. Moreover, as IP3-induced calcium oscillations
occur predominantly at the G1/S transition, these data are consistent
with the hypothesis that calcium transients may be involved in cell
cycle progression. However, it is important to consider that the effects
observed on proliferation and progression of the cell cycle by IP3R
agonists and antagonists may be independent of calcium waves. For
example, it is possible that activation of MAPK, phosphatidylinositol
3-kinase (PI3 kinase), and protein Kinase A pathway by IP3R agonists
[8,82,83] leads to increased proliferation. The ﬁnding that blocking
calcium oscillations with RyR antagonists in NPCs also decrease
proliferation [13] argues against this possibility. These oscillations
may induce mitosis by activating calmodulin (CaM), which in turn
may regulate the Ras/Raf/MEK/ERK pathway. CaM-binding proteins
such as Ras-GRF and CaM-dependent protein kinase IV positively
modulate ERK1/2 activation induced by either NGF or membrane
depolarization [52,53,84]. These pathways play a role in initiating
mitosis and are known to be activated by calcium oscillations
[1,53,84].
However, data concerning the importance of these transients in
cell cycle progression are contradictory. On one hand, data supporting
a role for IP3-mediated calcium oscillations in progression of the cell
cycle are abundant. It has been shown that mitosis can be initiated by
IP3R-induced calcium transients in mouse embryos [85], sea urchin
embryos [86], and in CSC and MSCs (Fig. 6). Moreover, in the sea
urchin embryo amicroinjection of calcium or IP3 can induce entry into
mitosis [86,87]. Conversely, microinjection of calcium chelators blocks
entry into mitosis [86–88]. Furthermore, an increase in IP3 occurs
before entry in mitosis and again at anaphase [4], consistent with a
role for IP3 in generating the calcium signals. On the other hand, some
reports suggest that calcium transients are not required for progres-
sion of the cell cycle. For instance, high concentrations of calcium
chelators abolish mitotic transients, but do not affect entry into
mitosis [85]. Furthermore, in mouse embryos inhibition of IP3Rs using
2-APB also abolishes calcium transients without affectingmitosis [85].
These data suggest that mitotic calcium signals are an epiphenom-
enon unrelated to cell cycle control.
The picture that emerges from these seemingly contradictory
results is that measurements of intracellular calcium do not always
support the idea that calcium transients are essential during mitosis.
This led to the idea that mitotic calcium signals may occur in
microdomains in many instances and that the larger transients may
represent ampliﬁcation of these small and localized calcium signals
under some experimental conditions [89–91]. Some authors speculate
that the calcium signals that control mitotic progression may occur in
calcium microdomains so localized as to be undetectable in global
calcium images. Thus, it is possible that undetectable calciumincreases in microdomains initiate mitosis in reports which suggest
that global calcium changes are not relevant for mitosis [42,76,77],
although future studies are need the clarify this issue.
In the present study we have demonstrated that undifferentiated
CSCs and adult MSCs exhibit IP3R-mediated [Ca2+]i oscillations, while
in NPCs both IP3Rs and RyRs mediate these oscillations. Interestingly
calcium transients occur predominantly at the G1/S transition
suggesting a role for these calcium transients in progression of the
cell cycle. This hypothesis is supported by the ﬁnding that IP3R
activation increases both the fraction of cells in G2/M and cell
proliferation rates. The present results give further insight into the
mechanisms that control progression of the cell cycle in stem cells as
distinct as CSCs and MSCs, describing a signaling mechanism that
could promote rapid transition out of G1 and therefore support the
preservation of their pluripotent state.
Author disclosure statement
No competing ﬁnancial interests exist.
Acknowledgments
Thisworkwas supportedby InstitutoNacionaldeCiência eTecnologia
de Nanomateriais de Carbono, CNPq (Conselho Nacional de Desenvolvi-
mento Cientíﬁco e Tecnológico), and Rede Mineira de Biotecnologia e
Bioensaios (FAPEMIG, Fundação de Amparo à Pesquisa do Estado de
MinasGerais) Brazil. R.R.R, S.G. and L.O.L. is grateful for grants fromCNPq,
and FAPEMIG, Brazil. A.H.K. is grateful for grants from CNPq, and FAPESP.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.bbamcr.2009.11.008.
References
[1] M.J. Berridge, Calcium signalling and cell proliferation, Bioessays 17 (1995)
491–500.
[2] L. Santella, The role of calcium in the cell cycle: facts and hypotheses, Biochem.
Biophys. Res Commun. 244 (1998) 317–324.
[3] S.M. Ribeiro, H.A. Armelin, Ca2+ and Mg2+ requirements for growth are not
concomitantly reduced during cell transformation, Mol. Cell. Biochem. 59 (1984)
173–181.
[4] B. Ciapa, D. Pesando, M.Wilding, M.Whitaker, Cell-cycle calcium transients driven
by cyclic changes in inositol trisphosphate levels, Nature 368 (1994) 875–878.
[5] L. Munaron, S. Antoniotti, A. Fiorio Pla, D. Lovisolo, Blocking Ca2+ entry: a way to
control cell proliferation, Curr. Med. Chem. 11 (2004) 1533–1543.
[6] R.A. Hickie, J.W. Wei, L.M. Blyth, D.Y. Wong, D.J. Klaassen, Cations and calmodulin
in normal and neoplastic cell growth regulation, Can. J. Biochem. Cell Biol.=Rev.
Can. Biochim. Biol. Cell. 61 (1983) 934–941.
[7] D.F. Owens, A.R. Kriegstein, Patterns of intracellular calcium ﬂuctuation in
precursor cells of the neocortical ventricular zone, J. Neurosci. 18 (1998)
5374–5388.
[8] T.A. Weissman, P.A. Riquelme, L. Ivic, A.C. Flint, A.R. Kriegstein, Calcium waves
propagate through radial glial cells and modulate proliferation in the developing
neocortex, Neuron 43 (2004) 647–661.
[9] E. Scemes, N. Duval, P. Meda, Reduced expression of P2Y1 receptors in
connexin43-null mice alters calcium signaling and migration of neural progenitor
cells, J. Neurosci. 23 (2003) 11444–11452.
[10] S. Kawano, S. Shoji, S. Ichinose, K. Yamagata, M. Tagami, M. Hiraoka,
Characterization of Ca(2+) signaling pathways in human mesenchymal stem
cells, Cell Calcium 32 (2002) 165–174.
[11] E. Yanagida, S. Shoji, Y. Hirayama, F. Yoshikawa, K. Otsu, H. Uematsu, M. Hiraoka, T.
Furuichi, S. Kawano, Functional expression of Ca2+ signaling pathways in mouse
embryonic stem cells, Cell Calcium 36 (2004) 135–146.
[12] M. Catsicas, V. Bonness, D. Becker, P. Mobbs, Spontaneous Ca2+ transients and
their transmission in the developing chick retina, Curr. Biol. 8 (1998) 283–286.
[13] R.R. Resende, J.L. da Costa, A.H. Kihara, A. Adhikari, E. Lorencon, Intracellular
Ca(2+) regulation during neuronal differentiation of murine embryonal
carcinoma and mesenchymal stem cells, Stem Cells Dev in press (2008).
[14] R. Pearson, M. Catsicas, D. Becker, P. Mobbs, Purinergic and muscarinic
modulation of the cell cycle and calcium signaling in the chick retinal ventricular
zone, J. Neurosci. 22 (2002) 7569–7579.
[15] S.E. Webb, A.L. Miller, Calcium signalling during embryonic development, Nat.
Rev. 4 (2003) 539–551.
[16] M.M. Syed, S. Lee, S. He, Z.J. Zhou, Spontaneous waves in the ventricular zone of
developing mammalian retina, J. Neurophysiol. 91 (2004) 1999–2009.
259R.R. Resende et al. / Biochimica et Biophysica Acta 1803 (2010) 246–260[17] N. Kapur, G.A. Mignery, K. Banach, Cell cycle-dependent calcium oscillations in
mouse embryonic stem cells, Am. J. Physiol. 292 (2007) C1510–1518.
[18] S. Geley, E. Kramer, C. Gieffers, J. Gannon, J.M. Peters, T. Hunt, Anaphase-
promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at
the beginning of mitosis and is not subject to the spindle assembly checkpoint,
J. Cell Biol. 153 (2001) 137–148.
[19] F. Santiago, E. Clark, S. Chong, C. Molina, F. Mozafari, R. Mahieux, M. Fujii, N. Azimi,
F. Kashanchi, Transcriptional up-regulation of the cyclin D2 gene and acquisition
of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1r-
infected cells, J. Virol. 73 (1999) 9917–9927.
[20] R.R. Resende, P. Majumder, K.N. Gomes, L.R. Britto, H. Ulrich, P19 embryonal
carcinoma cells as in vitro model for studying purinergic receptor expression and
modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors
during neuronal differentiation, Neuroscience 146 (2007) 1169–1181.
[21] R.R. Resende, K.N. Gomes, A. Adhikari, L.R. Britto, H. Ulrich, Mechanism of
acetylcholine-induced calcium signaling during neuronal differentiation of P19
embryonal carcinoma cells in vitro, Cell Calcium 43 (2008) 107–121.
[22] R.R. Resende, A.S. Alves, L.R. Britto, H. Ulrich, Role of acetylcholine receptors in
proliferation and differentiation of P19 embryonal carcinoma cells, Exp. Cell Res.
314 (2008) 1429–1443.
[23] A. Adhikari, C.A. Penatti, R.R. Resende, H. Ulrich, L.R. Britto, E.J. Bechara, 5-
Aminolevulinate and 4, 5-dioxovalerate ions decrease GABA(A) receptor density
in neuronal cells, synaptosomes and rat brain, Brain Res. 1093 (2006) 95–104.
[24] J.R. Sanchez-Ramos, S. Song, S.G. Kamath, T. Zigova, A. Willing, F. Cardozo-Pelaez,
T. Stedeford, M. Chopp, P.R. Sanberg, Expression of neural markers in human
umbilical cord blood, Exp. Neurol. 171 (2001) 109–115.
[25] M. Suzuki, K. Muraki, Y. Imaizumi, M. Watanabe, Cyclopiazonic acid, an inhibitor
of the sarcoplasmic reticulum Ca(2+)-pump, reduces Ca(2+)-dependent K+
currents in guinea-pig smooth muscle cells, Br. J. Pharmacol. 107 (1992) 134–140.
[26] O. Thastrup, P.J. Cullen, B.K. Drobak, M.R. Hanley, A.P. Dawson, Thapsigargin, a
tumor promoter, discharges intracellular Ca2+ stores by speciﬁc inhibition of the
endoplasmic reticulum Ca2(+)-ATPase, Proc. Natl. Acad. Sci. U. S. A. 87 (1990)
2466–2470.
[27] S.C. Taylor, C. Peers, Store-operated Ca2+ inﬂux and voltage-gated Ca2+
channels coupled to exocytosis in pheochromocytoma (PC12) cells, J. Neurochem.
73 (1999) 874–880.
[28] J. Gafni, J.A. Munsch, T.H. Lam, M.C. Catlin, L.G. Costa, T.F. Molinski, I.N. Pessah,
Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-
trisphosphate receptor, Neuron 19 (1997) 723–733.
[29] H.H. Kerschbaum, M.D. Cahalan, Single-channel recording of a store-operated
Ca2+ channel in Jurkat T lymphocytes, Science (New York, NY) 283 (1999)
836–839.
[30] A. Zweifach, R.S. Lewis, Calcium-dependent potentiation of store-operated
calcium channels in T lymphocytes, J. Gen. Physiol. 107 (1996) 597–610.
[31] H.H. Kerschbaum, M.D. Cahalan, Monovalent permeability, rectiﬁcation, and ionic
block of store-operated calcium channels in Jurkat T lymphocytes, J. Gen. Physiol.
111 (1998) 521–537.
[32] T. Maruyama, T. Kanaji, S. Nakade, T. Kanno, K. Mikoshiba, 2APB, 2-aminoethox-
ydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced
Ca2+ release, J. Biochem. 122 (1997) 498–505.
[33] M. Fill, J.A. Copello, Ryanodine receptor calcium release channels, Physiol. Rev. 82
(2002) 893–922.
[34] A. Beck, R.Z. Nieden, H.P. Schneider, J.W. Deitmer, Calcium release from
intracellular stores in rodent astrocytes and neurons in situ, Cell Calcium 35
(2004) 47–58.
[35] J. Meldolesi, Rapidly exchanging Ca2+ stores in neurons: molecular, structural
and functional properties, Prog. Neurobiol. 65 (2001) 309–338.
[36] D.I. Yule, J.A. Williams, U73122 inhibits Ca2+ oscillations in response to
cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells,
J. Biol. Chem. 267 (1992) 13830–13835.
[37] T.A. Ta, W. Feng, T.F. Molinski, I.N. Pessah, Hydroxylated xestospongins block
inositol-1,4,5-trisphosphate-induced Ca2+ release and sensitize Ca2+-induced
Ca2+ release mediated by ryanodine receptors, Mol. Pharmacol. 69 (2006)
532–538.
[38] D.O. Mak, S. McBride, J.K. Foskett, ATP-dependent adenophostin activation of
inositol 1,4,5-trisphosphate receptor channel gating: kinetic implications for the
durations of calcium puffs in cells, J. Gen. Physiol. 117 (2001) 299–314.
[39] M. Takahashi, K. Tanzawa, S. Takahashi, Adenophostins, newly discovered
metabolites of Penicillium brevicompactum, act as potent agonists of the inositol
1,4,5-trisphosphate receptor, J. Biol. Chem. 269 (1994) 369–372.
[40] C. Clair, C. Chalumeau, T. Tordjmann, J. Poggioli, C. Erneux, G. Dupont, L.
Combettes, Investigation of the roles of Ca(2+) and InsP(3) diffusion in the
coordination of Ca(2+) signals between connected hepatocytes, J. Cell Sci. 114
(2001) 1999–2007.
[41] T. Krude, Mimosine arrests proliferating human cells before onset of DNA
replication in a dose-dependent manner, Exp. Cell Res. 247 (1999) 148–159.
[42] C.Y. Gui, C. Jiang, H.Y. Xie, R.L. Qian, The apoptosis of HEL cells induced by
hydroxyurea, Cell Res. 7 (1997) 91–97.
[43] I. Nishiyama, T. Fujii, Laminin-induced process outgrowth from isolated fetal rat
C-cells, Exp. Cell Res. 198 (1992) 214–220.
[44] M.A. Jordan, D. Thrower, L. Wilson, Effects of vinblastine, podophyllotoxin and
nocodazole onmitotic spindles. Implications for the role of microtubule dynamics
in mitosis, J. Cell Sci. 102 (Pt. 3) (1992) 401–416.
[45] R.L. da Silva, R.R. Resende, H. Ulrich, Alternative splicing of P2X6 receptors in
developing mouse brain and during in vitro neuronal differentiation, Exp. Physiol.
92 (2007) 139–145.[46] N. Mackman, K. Brand, T.S. Edgington, Lipopolysaccharide-mediated transcrip-
tional activation of the human tissue factor gene in THP-1 monocytic cells
requires both activator protein 1 and nuclear factor kappa B binding sites, J. Exp.
Med. 174 (1991) 1517–1526.
[47] M.M. Bradford, A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem.
72 (1976) 248–254.
[48] E. Stead, J. White, R. Faast, S. Conn, S. Goldstone, J. Rathjen, U. Dhingra, P. Rathjen,
D. Walker, S. Dalton, Pluripotent cell division cycles are driven by ectopic Cdk2,
cyclin A/E and E2F activities, Oncogene 21 (2002) 8320–8333.
[49] R.R. Resende, L.R. Britto, H. Ulrich, Pharmacological properties of purinergic
receptors and their effects on proliferation and induction of neuronal differen-
tiation of P19 embryonal carcinoma cells, Int. J. Dev. Neurosci. 26 (2008) 763–777.
[50] R.L. Patterson, D. Boehning, S.H. Snyder, Inositol 1,4,5-trisphosphate receptors as
signal integrators, Annu. Rev. Biochem. 73 (2004) 437–465.
[51] A. Verkhratsky, Endoplasmic reticulum calcium signaling in nerve cells, Biol. Res.
37 (2004) 693–699.
[52] M.J. Berridge, P. Lipp, M.D. Bootman, The versatility and universality of calcium
signalling, Nat. Rev. 1 (2000) 11–21.
[53] M.J. Berridge, The endoplasmic reticulum: a multifunctional signaling organelle,
Cell Calcium 32 (2002) 235–249.
[54] M. D'Ascenzo, R. Piacentini, P. Casalbore, M. Budoni, R. Pallini, G.B. Azzena, C.
Grassi, Role of L-type Ca2+ channels in neural stem/progenitor cell differenti-
ation, Eur. J. Neurosci. 23 (2006) 935–944.
[55] H.M. Yu, J. Wen, R. Wang, W.H. Shen, S. Duan, H.T. Yang, Critical role of type 2
ryanodine receptor in mediating activity-dependent neurogenesis from embry-
onic stem cells, Cell Calcium 43 (2008) 417–431.
[56] B.E. Ehrlich, E. Kaftan, S. Bezprozvannaya, I. Bezprozvanny, The pharmacology
of intracellular Ca(2+)-release channels, Trends Pharmacol. Sci. 15 (1994)
145–149.
[57] Y.W. Peng, A.H. Sharp, S.H. Snyder, K.W. Yau, Localization of the inositol 1,4,5-
trisphosphate receptor in synaptic terminals in the vertebrate retina, Neuron 6
(1991) 525–531.
[58] J. Gan, P.M. Iuvone, Depolarization and activation of dihydropyridine-sensitive
Ca2+ channels stimulate inositol phosphate accumulation in photoreceptor-
enriched chick retinal cell cultures, J. Neurochem. 68 (1997) 2300–2307.
[59] S. Osada, Y. Okano, S. Saji, Y. Nozawa, Spontaneous Ca2+ release from a caffeine
and ryanodine-sensitive intracellular Ca2+ store in freshly prepared hepatocytes,
Hepatology (Baltimore, Md.) 19 (1994) 514–517.
[60] D.D. Friel, R.W. Tsien, A caffeine- and ryanodine-sensitive Ca2+ store in bullfrog
sympathetic neurones modulates effects of Ca2+ entry on [Ca2+]i, J. Physiol. 450
(1992) 217–246.
[61] L.L. Haak, L.S. Song, T.F. Molinski, I.N. Pessah, H. Cheng, J.T. Russell, Sparks and
puffs in oligodendrocyte progenitors: cross talk between ryanodine receptors and
inositol trisphosphate receptors, J. Neurosci. 21 (2001) 3860–3870.
[62] E.G. Harks, J.P. Camina, P.H. Peters, D.L. Ypey, W.J. Scheenen, E.J. van Zoelen, A.P.
Theuvenet, Besides affecting intracellular calcium signaling, 2-APB reversibly
blocks gap junctional coupling in conﬂuent monolayers, thereby allowing
measurement of single-cell membrane currents in undissociated cells, FASEB J.
17 (2003) 941–943.
[63] D. Bai, C. del Corsso, M. Srinivas, D.C. Spray, Block of speciﬁc gap junction channel
subtypes by 2-aminoethoxydiphenyl borate (2-APB), J. Pharmacol. Exp. Ther. 319
(2006) 1452–1458.
[64] C.M. Peppiatt, T.J. Collins, L. Mackenzie, S.J. Conway, A.B. Holmes, M.D. Bootman,
M.J. Berridge, J.T. Seo, H.L. Roderick, 2-Aminoethoxydiphenyl borate (2-APB)
antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calci-
um pumps and has a use-dependent and slowly reversible action on store-
operated calcium entry channels, Cell Calcium 34 (2003) 97–108.
[65] C.L. He, P. Damiani, J.B. Parys, R.A. Fissore, Calcium, calcium release receptors, and
meiotic resumption in bovine oocytes, Biol. Reprod. 57 (1997) 1245–1255.
[66] L. Wang, K.L. White, W.A. Reed, K.D. Campbell, Dynamic changes to the inositol
1,4,5-trisphosphate and ryanodine receptors during maturation of bovine
oocytes, Cloning Stem Cells 7 (2005) 306–320.
[67] L. Groigno, M. Whitaker, An anaphase calcium signal controls chromosome
disjunction in early sea urchin embryos, Cell 92 (1998) 193–204.
[68] T. Hunter, J. Pines, Cyclins and cancer: II. Cyclin D and CDK inhibitors come of age,
Cell 79 (1994) 573–582.
[69] D.O. Morgan, Principles of CDK regulation, Nature 374 (1995) 131–134.
[70] C.J. Sherr, G1 phase progression: cycling on cue, Cell 79 (1994) 551–555.
[71] I. Reynisdottir, K. Polyak, A. Iavarone, J. Massague, Kip/Cip and Ink4 Cdk inhibitors
cooperate to induce cell cycle arrest in response to TGF-beta, Genes Dev. 9 (1995)
1831–1845.
[72] C.J. Sherr, J.M. Roberts, CDK inhibitors: positive and negative regulators of G1-
phase progression, Genes Dev. 13 (1999) 1501–1512.
[73] M.J. Berridge, M.D. Bootman, H.L. Roderick, Calcium signalling: dynamics,
homeostasis and remodelling, Nat. Rev. 4 (2003) 517–529.
[74] G.S. Williams, E.J. Molinelli, G.D. Smith, Modeling local and global intracellular
calcium responses mediated by diffusely distributed inositol 1,4,5-trisphosphate
receptors, J. Theor. Biol. 253 (2008) 170–188.
[75] T. Matsu-ura, T. Michikawa, T. Inoue, A. Miyawaki, M. Yoshida, K. Mikoshiba,
Cytosolic inositol 1,4,5-trisphosphate dynamics during intracellular calcium
oscillations in living cells, J. Cell Biol. 173 (2006) 755–765.
[76] L. Santella, E. Ercolano, G.A. Nusco, The cell cycle: a new entry in the ﬁeld of Ca2+
signaling, Cell Mol. Life Sci. 62 (2005) 2405–2413.
[77] C.W. Taylor, A.J. Laude, IP3 receptors and their regulation by calmodulin and
cytosolic Ca2+, Cell Calcium 32 (2002) 321–334.
260 R.R. Resende et al. / Biochimica et Biophysica Acta 1803 (2010) 246–260[78] G. Halet, R. Tunwell, S.J. Parkinson, J. Carroll, Conventional PKCs regulate the
temporal pattern of Ca2+ oscillations at fertilization in mouse eggs, J. Cell Biol.
164 (2004) 1033–1044.
[79] L. Jirmanova, M. Afanassieff, S. Gobert-Gosse, S. Markossian, P. Savatier,
Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1
expression and to the control of the G1/S transition in mouse embryonic stem
cells, Oncogene 21 (2002) 5515–5528.
[80] J.S. Heo, Y.J. Lee, H.J. Han, EGF stimulates proliferation of mouse embryonic stem
cells: involvement of Ca2+ inﬂux and p44/42 MAPKs, Am. J. Physiol. 290 (2006)
C123–C133.
[81] R.R. Resende, A. Adhikari, Cholinergic receptor pathways involved in apoptosis,
cell proliferation and neuronal differentiation, Cell Commun. Signal. 7 (2009)
20.
[82] N. DeSouza, S. Reiken, K. Ondrias, Y.M. Yang, S. Matkovich, A.R. Marks, Protein
kinase A and two phosphatases are components of the inositol 1,4,5-trispho-
sphate receptor macromolecular signaling complex, J. Biol. Chem. 277 (2002)
39397–39400.
[83] M. Hershﬁnkel, W.F. Silverman, I. Sekler, The zinc sensing receptor, a link
between zinc and cell signaling, Mol. Med. (Cambridge, Mass.) 13 (2007)
331–336.[84] N. Agell, O. Bachs, N. Rocamora, P. Villalonga, Modulation of the Ras/Raf/MEK/
ERK pathway by Ca(2+), and calmodulin, Cell. Signal. 14 (2002) 649–654.
[85] G. FitzHarris, M. Larman, C. Richards, J. Carroll, An increase in [Ca2+]i is sufﬁcient
but not necessary for driving mitosis in early mouse embryos, J. Cell Sci. 118
(2005) 4563–4575.
[86] J. Twigg, R. Patel, M. Whitaker, Translational control of InsP3-induced chromatin
condensation during the early cell cycles of sea urchin embryos, Nature 332
(1988) 366–369.
[87] R.A. Steinhardt, J. Alderton, Intracellular free calcium rise triggers nuclear
envelope breakdown in the sea urchin embryo, Nature 332 (1988) 364–366.
[88] M. Wilding, E.M. Wright, R. Patel, G. Ellis-Davies, M. Whitaker, Local perinuclear
calcium signals associated with mitosis-entry in early sea urchin embryos, J. Cell
Biol. 135 (1996) 191–199.
[89] T. Kono, K.T. Jones, A. Bos-Mikich, D.G. Whittingham, J. Carroll, A cell cycle-
associated change in Ca2+ releasing activity leads to the generation of Ca2+
transients in mouse embryos during the ﬁrst mitotic division, J. Cell Biol. 132
(1996) 915–923.
[90] J.P. Kao, J.M. Alderton, R.Y. Tsien, R.A. Steinhardt, Active involvement of Ca2+ in
mitotic progression of Swiss 3T3 ﬁbroblasts, J. Cell Biol. 111 (1990) 183–196.
[91] P.K. Hepler, The role of calcium in cell division, Cell Calcium 16 (1994) 322–330.
